French Observatory of ElectroConvulsive Therapy (ECT)
Launched by CENTRE HOSPITALIER HENRI LABORIT · Jul 15, 2020
Trial Information
Current as of May 22, 2025
Recruiting
Keywords
ClinConnect Summary
The French Observatory of ElectroConvulsive Therapy (ECT) is a clinical trial aimed at improving the understanding and use of ECT, a treatment that has been used since the 1930s primarily for severe depression that hasn't responded to other treatments. This study seeks to identify how ECT is currently being administered in France and to develop research that can enhance its effectiveness for various mental health conditions. Although ECT can be very helpful, it may also come with side effects, and there hasn't been a comprehensive update on treatment guidelines since 1997.
If you are a patient who has been referred for ECT, you may be eligible to participate in this trial, as it is open to individuals of all ages and genders. Participants can expect to have their experiences with ECT documented and analyzed to improve future care recommendations. This study is currently recruiting participants, and your involvement could help shape better treatment options for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients consecutively referred for ECT.
- Exclusion Criteria:
- • Not specified
About Centre Hospitalier Henri Laborit
Centre Hospitalier Henri Laborit is a leading healthcare institution committed to advancing medical research and patient care through innovative clinical trials. With a focus on a multidisciplinary approach, the center integrates cutting-edge technology and evidence-based practices to investigate new treatments and improve health outcomes. The hospital collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to ensure that its clinical studies are conducted with the highest standards of ethics and scientific rigor. By fostering a culture of collaboration and excellence, Centre Hospitalier Henri Laborit aims to contribute significantly to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Metz, , France
Bayonne, , France
Angers, , France
Anglet, , France
Avignon, , France
Bégard, , France
Caen, , France
Dijon, , France
Esvres Sur Indre, , France
Guipavas, , France
La Rochelle, , France
La Réunion, , France
Les Ponts De Ce, , France
Mayenne, , France
Monteléger, , France
Montpellier, , France
Nice, , France
Paris, , France
Poitiers, , France
Redon, , France
Rennes, , France
Rouen, , France
Saint Avé, , France
Saujon, , France
Strasbourg, , France
Thouars, , France
Toulon, , France
Toulouse, , France
Tours, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials